Insider · CIK 0001814673
Tomas J. Heyman
Files at EXEL (EXELIXIS, INC.), OPTN (OptiNose, Inc.), AKRO (Akero Therapeutics, Inc.), LEGN (Legend Biotech Corp). First filing May 22, 2025, latest May 22, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EXEL: EXELIXIS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | EXELIXIS, INC. | $201k 4,544 shares | -12% | +72% from low-5% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | LEGN Legend Biotech Corp | AGrant or award Ordinary Shares | +20,986 | $0.00 | $0 | 53,720 | 14 d ago |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | AGrant or award Common Stock | +9,398 | $0.00 | $0 | 9,398 | Jun 5, 2025 |
| May 29, 2025 | EXEL EXELIXIS, INC. | AGrant or award Common Stock | +9,812 | $0.00 | $0 | 42,282 | May 30, 2025 |
| May 21, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock | -4,544 | $44.29 | $201k | 32,470 | May 22, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,566 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,133 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -962 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,925 | - | - | 0 | May 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.